This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Rite Aid is selling more than 1,000 pharmacies to rival drugstore operators as the beleaguered pharmacy chain limps through bankruptcy processes for a second time. Rite Aid said it was formally pursuing sales of “substantially all of its assets” earlier this month. Now, healthcare companies CVS Health and Walgreens, along with grocery stores Albertsons, Kroger and Giant Eagle, are among the buyers snapping up Rite Aid stores, the company said on Thursday. CVS is one of the biggest buyers, agreeing to acquire prescription files from 625 Rite Aid locations in 15 states in areas where it already has a presence, along with fully buying and operating 64 stores in Idaho, Oregon and Washington. The sales are subject to approval by a New Jersey bankruptcy court, which is scheduled to hold a hearing on May 21 regarding the transactions. Dive Insight: Rite Aid used to be a pharmacy juggernaut with 2,100 pharmacies in 17 states, and 60 years of operations under its belt. The Pennsylvania-based company brought in more than $24 billion in annual revenue in 2023. But Rite Aid wrestled with challenges facing legacy drugstores, including flatlining reimbursement rates from payers, higher labor costs, lower consumer demand for frontstore merchandise and rising competition, including from disruptors like Amazon. Rite Aid also struggled to part ways with unprofitable stores due to sticky lease agreements — while it was on the hook for massive payouts to settle lawsuits over its role in furthering the opioid epidemic. The company first filed for Chapter 11 bankruptcy in 2023 after reaching roughly $4 billion in debt. The goal was to restructure Rite Aid for long-term success, executives said at the time. Rite Aid emerged from bankruptcy last fall as a private company with its debt cut in half, a new CEO and a smaller store footprint. But eight months later, Rite Aid found itself back in the same position earlier this month when it filed for bankruptcy a second time, citing unforeseen liquidity issues. At that point, the company operated almost 1,300 stores in 15 states, but said it planned to pursue sales of its assets in an attempt to make its debtors whole. Rite Aid auctioned off its pharmacy assets over video conference on Wednesday after receiving multiple qualified bids, according to court documents. Those assets include prescription files, which are the drug dispensing records from a specific pharmacy. Pharmacies can acquire prescription files from other locations to grow their business — the tactic CVS is pursuing here by nabbing hundreds of Rite Aid’s prescription files in locations where it already operates stores. Story Continues Financial details about the sales have not yet been disclosed, but additional information will likely be available following the May 21 hearing. A spokesperson for Rite Aid did not provide additional information on the deals beyond what was in the Thursday press release. The sales, which will be implemented on a rolling basis, are still subject to court and regulatory approvals. Rite Aid’s stores will remain open during the divestiture process to ensure continuity of care for its customers, the company said. “These agreements ensure our pharmacy customers will experience a smooth transition while preserving jobs for some of our valued team members,” Rite Aid CEO Matt Schroeder said in a statement. Recommended Reading Rite Aid files for bankruptcy 8 months after exiting Chapter 11 View Comments
Rite Aid sells upwards of 1,000 stores to CVS, Walgreens, others
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...